Y020-2503 Screening compound: 1-[7-(2-chlorophenyl)-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonyl]-4-methylpiperazine

Y020-2503 Screening compound: 1-[7-(2-chlorophenyl)-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonyl]-4-methylpiperazine
Y020-2503 Screening compound: 1-[7-(2-chlorophenyl)-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonyl]-4-methylpiperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-2503
1-[7-(2-chlorophenyl)-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonyl]-4-methylpiperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-2503

Molecular Formula

C18H21ClN6O (C18 H21 ClN6 O)

Compound Name

1-[7-(2-chlorophenyl)-5-methyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonyl]-4-methylpiperazine

IUPAC name

1-[7-(2-chlorophenyl)-5-methyl-4H7H-[124]triazolo[15-a]pyrimidine-6-carbonyl]-4-methylpiperazine

SMILES

CC(Nc1ncnn1C1c(cccc2)c2Cl)=C1C(N1CCN(C)CC1)=O

InChI

InChI=1S/C18H21ClN6O/c1-12-15(17(26)24-9-7-23(2)8-10-24)16(13-5-3-4-6-14(13)19)25-18(22-12)20-11-21-25/h3-6,11,16H,7-10H2,1-2H3,(H,20,21,22)/t16-/m0/s1

InChI Key

FZTJSORNBPDBEG-INIZCTEOSA-N

MDL Number (MFCD)

MFCD08709864

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

372.86

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.841

Distribution Coefficient, logD

1.407

Water Solubility, LogSw

-2.54

Polar Surface Area

58.115

Acid Dissociation Constant (pKa)

8.37

Base Dissociation Constant (pKb)

7.64

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.90

Y020-2503 in Drug Discovery

Included in Screening Libraries

BRD4 Targeted Library (4534 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with Y020-2503 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-2503?
Check Price and Availability of Y020-2503, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-2503 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-2503
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-2503
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-2503 available by request